Recently, as the prescription of GLP-1 receptor agonists, which is in the spotlight as a treatment for obesity, side effects ...

Fangzhou & Novo Nordisk sign MoU to establish a new ecosystem for health management: Beijing Monday, July 21, 2025, 17:00 Hrs [IST] Fangzhou Inc., a leader in Internet healthcare ...

Certain urine biomarkers may noninvasively assess kidney health in patients with diabetic kidney disease and help identify ...

Innovative stem cell therapy shows promise in restoring insulin production for severe type 1 diabetes patients.

Prescription drugs account for 15% of health care costs. Yet, they’re our best defense against the chronic diseases that ...

Stroke is not just a disease of older people—it can happen to anyone at any age, often with devastating, life-long ...

Drug development is a decade-long and costly process replete with failures. If we don’t incentivize continued investments in ...

After heat exhaustion in summer, erratic rainfall has increased the price of vegetables and made it difficult for people to ...

More than 40% of Americans are obese, according to the Centers for Disease Control and Prevention (CDC). And the epidemic isn ...

AI offers promise in the realm of chronic disease management, including diabetes, obesity, and PCOS, but must be approached with caution.

Diabetes in India leads to severe complications like neuropathy and blindness, highlighting the need for better disability ...

Scientists are gaining more understanding of diabetes and prediabetes by combining genomics with continuous glucose ...